Darzalex Faspro 57894-0503-01
Generic: Daratumumab And Hyaluronidase-Fihj (human Recombinant)
- Manufacturer
- Janssen Biotech, Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2020
- Listing Expires
- December 31, 2027
- Application
- BLA761145
Need to source Darzalex Faspro? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Daratumumab | 1800 mg/15mL |
| Hyaluronidase (human Recombinant) | 30000 U/15mL |
Drug Class
CD38-directed Cytolytic Antibody [EPC]Endoglycosidase [EPC]Antibodies
Selected Package
57894-0503-01Selected1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01) / 15 mL in 1 VIAL, SINGLE-DOSE
External Resources